Analyses of Predictors of Durable Treatment-Free Remission in Patients with Chronic Myeloid Leukemia in Chronic Phase Following Frontline or Second-Line Nilotinib

被引：1
|
作者：
Radich, Jerald P. [1 ]
Hochhaus, Andreas [2 ]
Giles, Francis J. [3 ]
Ross, David M. [4 ]
Saglio, Giuseppe [5 ]
Hughes, Timothy P. [6 ]
Kim, Dong-Wook [7 ]
Fellague-Chebra, Rafik [8 ]
Sondhi, Manu [9 ]
Tiwari, Ranjan [10 ]
Mishra, Kaushal [9 ]
Mahon, Francois-Xavier [11 ]
机构：
[1] Fred Hutchinson Canc Res Ctr, Div Clin Res, 1124 Columbia St, Seattle, WA 98104 USA
[2] Univ Klinikum Jena, Jena, Germany
[3] Dev Therapeut Consortium, Chicago, IL USA
[4] Royal Adelaide Hosp, Div Haematol, SA Pathol, Adelaide, SA, Australia
[5] Univ Turin, Div Internal Med & Hematol, Orbassano, Italy
[6] SAHMRI, Adelaide, SA, Australia
[7] Catholic Univ Korea, Seoul St Marys Hosp, Leukemia Res Inst, Seoul, South Korea
[8] Novartis Pharma SAS, Rueil Malmaison, France
[9] Novartis Pharmaceut, E Hanover, NJ USA
[10] Novartis Healthcare Pvt Ltd, Hyderabad, Telangana, India
[11] Univ Bordeaux, Inst Bergonie, Canc Ctr Bordeaux, INSERM,U1218, Bordeaux, France
来源：
BLOOD | 2019年 / 134卷
关键词：
D O I：
10.1182/blood-2019-129393
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
2932
引用
收藏
页数：3
相关论文
共 50 条
  • [1] Predictors of Durable Treatment-Free Remission After Frontline or Second-Line Nilotinib Treatment in Patients with Chronic Phase Chronic Myeloid Leukemia
    Radich, Jerald
    Hochhaus, Andreas
    Giles, Francis
    Ross, David
    Saglio, Giuseppe
    Hughes, Timothy
    Kim, Dong-Wook
    Fellague-Chebra, Rafik
    Tiwari, Ranjan
    Mishra, Kaushal
    Mahon, Francois-Xavier
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2020, 20 : S233 - S234
  • [2] Treatment-Free Remission After Second-Line Nilotinib Treatment in Patients With Chronic Myeloid Leukemia in Chronic Phase
    Mahon, Francois-Xavier
    Boquimpani, Carla
    Kim, Dong-Wook
    Benyamini, Noam
    Clementino, Nelma Cristina D.
    Shuvaev, Vasily
    Ailawadhi, Sikander
    Lipton, Jeffrey Howard
    Turkina, Anna G.
    De Paz, Raquel
    Moiraghi, Beatriz
    Nicolini, Franck E.
    Dengler, Jolanta
    Sacha, Tomasz
    Takahashi, Naoto
    Fellague-Chebra, Rafik
    Acharya, Sandip
    Wong, Stephane
    Jin, Yu
    Hughes, Timothy P.
    ANNALS OF INTERNAL MEDICINE, 2018, 168 (07) : 461 - +
  • [3] DURABLE TREATMENT-FREE REMISSION AFTER STOPPING SECOND-LINE NILOTINIB IN PATIENTS WITH CHRONIC MYELOID LEUKEMIA IN CHRONIC PHASE: ENESTOP 96-WK UPDATE
    Hughes, T.
    Boquimpani, C.
    Takahashi, N.
    Benyamini, N.
    Clementino, N. C.
    Shuvaev, V.
    Ailawadhi, S.
    Lipton, J.
    Turkina, A.
    de Paz, R.
    Moiraghi, B.
    Nicolini, F.
    Dengler, J.
    Sacha, T.
    Kim, D. -W.
    Fellague-Chebra, R.
    Acharya, S.
    Krunic, N.
    Jin, Y.
    Mahon, F. -X.
    HAEMATOLOGICA, 2017, 102 : 75 - 75
  • [4] Durable treatment-free remission in patients with chronic myeloid leukemia in chronic phase following frontline nilotinib: 96-week update of the ENESTfreedom study
    Ross, David M.
    Masszi, Tamas
    Gomez Casares, Maria Teresa
    Hellmann, Andrzej
    Stentoft, Jesper
    Conneally, Eibhlin
    Garcia-Gutierrez, Valentin
    Gattermann, Norbert
    le Coutre, Philipp D.
    Martino, Bruno
    Saussele, Susanne
    Giles, Francis J.
    Radich, Jerald P.
    Saglio, Giuseppe
    Deng, Weiping
    Krunic, Nancy
    Bedoucha, Veronique
    Gopalakrishna, Prashanth
    Hochhaus, Andreas
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2018, 144 (05) : 945 - 954
  • [5] Durable treatment-free remission in patients with chronic myeloid leukemia in chronic phase following frontline nilotinib: 96-week update of the ENESTfreedom study
    David M. Ross
    Tamas Masszi
    María Teresa Gómez Casares
    Andrzej Hellmann
    Jesper Stentoft
    Eibhlin Conneally
    Valentin Garcia-Gutierrez
    Norbert Gattermann
    Philipp D. le Coutre
    Bruno Martino
    Susanne Saussele
    Francis J. Giles
    Jerald P. Radich
    Giuseppe Saglio
    Weiping Deng
    Nancy Krunic
    Véronique Bédoucha
    Prashanth Gopalakrishna
    Andreas Hochhaus
    Journal of Cancer Research and Clinical Oncology, 2018, 144 : 945 - 954
  • [6] Treatment-free remission following frontline nilotinib in patients with chronic myeloid leukemia in chronic phase: results from the ENESTfreedom study
    Hochhaus, A.
    Masszi, T.
    Giles, F. J.
    Radich, J. P.
    Ross, D. M.
    Gomez Casares, M. T.
    Hellmann, A.
    Stentoft, J.
    Conneally, E.
    Garcia-Gutierrez, V.
    Gattermann, N.
    Wiktor-Jedrzejczak, W.
    le Coutre, P. D.
    Martino, B.
    Saussele, S.
    Menssen, H. D.
    Deng, W.
    Krunic, N.
    Bedoucha, V.
    Saglio, G.
    LEUKEMIA, 2017, 31 (07) : 1525 - 1531
  • [7] Treatment-free remission following frontline nilotinib in patients with chronic myeloid leukemia in chronic phase: results from the ENESTfreedom study
    A Hochhaus
    T Masszi
    F J Giles
    J P Radich
    D M Ross
    M T Gómez Casares
    A Hellmann
    J Stentoft
    E Conneally
    V García-Gutiérrez
    N Gattermann
    W Wiktor-Jedrzejczak
    P D le Coutre
    B Martino
    S Saussele
    H D Menssen
    W Deng
    N Krunic
    V Bedoucha
    G Saglio
    Leukemia, 2017, 31 : 1525 - 1531
  • [8] Treatment-free remission following frontline nilotinib in patients with chronic phase chronic myeloid leukemia: 5-year update of the ENESTfreedom trial
    Jerald P. Radich
    Andreas Hochhaus
    Tamás Masszi
    Andrzej Hellmann
    Jesper Stentoft
    María Teresa Gómez Casares
    J. Valentín García-Gutiérrez
    Eibhlin Conneally
    Philipp D. le Coutre
    Norbert Gattermann
    Bruno Martino
    Susanne Saussele
    Francis J. Giles
    David M. Ross
    Paola Aimone
    Sai Li
    Ksenia Titorenko
    Giuseppe Saglio
    Leukemia, 2021, 35 : 1344 - 1355
  • [9] Treatment-free remission following frontline nilotinib in patients with chronic phase chronic myeloid leukemia: 5-year update of the ENESTfreedom trial
    Radich, Jerald P.
    Hochhaus, Andreas
    Masszi, Tamas
    Hellmann, Andrzej
    Stentoft, Jesper
    Casares, Maria Teresa Gomez
    Garcia-Gutierrez, J. Valentin
    Conneally, Eibhlin
    le Coutre, Philipp D.
    Gattermann, Norbert
    Martino, Bruno
    Saussele, Susanne
    Giles, Francis J.
    Ross, David M.
    Aimone, Paola
    Li, Sai
    Titorenko, Ksenia
    Saglio, Giuseppe
    LEUKEMIA, 2021, 35 (05) : 1344 - 1355
  • [10] DURABLE TREATMENT-FREE REMISSION (TFR) FOLLOWING FRONTLINE NILOTINIB (NIL) IN PATIENTS (PTS) WITH CHRONIC MYELOID LEUKEMIA IN CHRONIC PHASE (CML-CP): ENESTFREEDOM 96-WK UPDATE
    Ross, D.
    Masszi, T.
    Gomez Casares, M. T.
    Hellmann, A.
    Stentoft, J.
    Conneally, E.
    Garcia Gutierrez, V.
    Gattermann, N.
    le Coutre, P.
    Martino, B.
    Saussele, S.
    Giles, F.
    Radich, J.
    Saglio, G.
    Gopalakrishna, P.
    Deng, W.
    Krunic, N.
    Bedoucha, V.
    Hochhaus, A.
    HAEMATOLOGICA, 2017, 102 : 235 - 235
12345